With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving beyond cancer and rare disease.
Drugmakers, Aetna alleged, determined their market allocation by providing high cover bids, or refusing to bid for some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback